ProCE Banner Activity

Rationale for Chemoimmunotherapy in Metastatic NSCLC and Latest Clinical Trial Data

Slideset

Downloadable slideset with the latest clinical data on the clinical rationale for chemoimmunotherapy in metastatic NSCLC and the latest clinical trial data.

Released: November 28, 2023

Share

Faculty

Christine M. Bestvina

Christine M. Bestvina, MD

Assistant Professor
Section of Hematology/Oncology
Division of Medicine
University of Chicago Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca